AboutAllison Heddon

As the leader of Sg2’s virtual health offerings, Allison focuses on emerging virtual health technologies and their impact on care delivery. She shapes corporate messaging and guides enterprise-wide technology acquisition strategies and virtual health implementation for US and international organizations. Within this role, she is also responsible for leading large-scale virtual health projects within Sg2 Consulting.

During her tenure at the firm, Allison has led the development of Sg2’s proprietary STEPTM (Sg2 Technology Evaluation and Prioritization) tool, designed a multiyear series on disruptive health care technology, facilitated numerous health system technology strategic planning retreats, and managed global technology assessments for large international technology vendors and pharmaceutical companies. Her previous Sg2 responsibilities spanned projects related to neurosciences and cardiovascular services, specifically stroke and endovascular care, trauma, epilepsy services, transcatheter aortic valve implantation, hybrid operating rooms, vascular services and interventional cardiology.

Allison has been named a “20 In Their 20s” by Crain’s Chicago Business, and her work has been published in the Journal of Medical Ethics. She is a frequent speaker at technology conferences and events across the country, is an editor for the Telemedicine and e-Health journal and has led innovation workshops at Singularity University’s Exponential Medicine Conference.

Allison is the cofounder of Resonance Medical, LLC, a neuroinformatics company that is developing novel brain-machine interfaces. She also mentors biotech start-ups at MATTER, a Chicago-based accelerator aiming to grow next-generation diagnostics, biopharma, health IT and medical device businesses.

Allison earned her master’s degree in bioethics and health policy from Loyola University Chicago and her bachelor’s degree in biology from Illinois Wesleyan University.

"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Facebook Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube